Ken Griffin’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.9M Sell
750,639
-1,101,568
-59% -$47.9M ﹤0.01% 2066
2026
Q2
$79M Buy
1,852,207
+364,237
+24% +$16.3M 0.01% 1150
2026
Q1
$71.7M Buy
1,487,970
+235,434
+19% +$11M 0.01% 1058
2025
Q4
$60.7M Buy
1,252,536
+481,099
+62% +$23.8M 0.01% 1252
2025
Q3
$36.4M Buy
771,437
+553,117
+253% +$26.7M 0.01% 1689
2025
Q2
$10.5M Buy
218,320
+166,487
+321% +$8.51M ﹤0.01% 2949
2025
Q1
$2.87M Sell
51,833
-32,127
-38% -$1.74M ﹤0.01% 4841
2024
Q4
$4.05M Sell
83,960
-91,633
-52% -$4.66M ﹤0.01% 4315
2024
Q3
$10.1M Buy
175,593
+50,150
+40% +$2.71M ﹤0.01% 2873
2024
Q2
$6.09M Buy
125,443
+72,582
+137% +$3.5M ﹤0.01% 3443
2024
Q1
$2.57M Sell
52,861
-70
-0.1% -$3.42K ﹤0.01% 5045
2023
Q4
$2.63M Buy
52,931
+39,232
+286% +$1.92M ﹤0.01% 4879
2023
Q3
$735K Buy
13,699
+13,508
+7,072% +$720K ﹤0.01% 7238
2023
Q2
$10.3K Sell
191
-89,812
-100% -$4.83M ﹤0.01% 13213
2023
Q1
$4.9M Buy
90,003
+28,111
+45% +$1.37M ﹤0.01% 3855
2022
Q4
$3M Sell
61,892
-333,233
-84% -$14.6M ﹤0.01% 4750
2022
Q3
$15M Buy
395,125
+236,347
+149% +$10.5M ﹤0.01% 2220
2022
Q2
$7.94M Buy
158,778
+77,093
+94% +$4.09M ﹤0.01% 2984
2022
Q1
$4.19M Sell
81,685
-81,474
-50% -$4.21M ﹤0.01% 4525
2021
Q4
$8.17M Buy
163,159
+94,472
+138% +$4.67M ﹤0.01% 3408
2021
Q3
$3.31M Sell
68,687
-128,097
-65% -$6.51M ﹤0.01% 5149
2021
Q2
$10.4M Sell
196,784
-131,616
-40% -$6.87M ﹤0.01% 3011
2021
Q1
$16.2M Buy
328,400
+888
+0.3% +$42.7K ﹤0.01% 2241
2020
Q4
$15.9M Sell
327,512
-130,713
-29% -$6.45M ﹤0.01% 2060
2020
Q3
$23M Buy
458,225
+100,874
+28% +$5.19M 0.01% 1452
2020
Q2
$18.2M Buy
357,351
+13,885
+4% +$675K 0.01% 1582
2020
Q1
$15M Buy
343,466
+36,337
+12% +$1.74M 0.01% 1479
2019
Q4
$15.4M Buy
307,129
+126,175
+70% +$5.91M 0.01% 1742
2019
Q3
$8.38M Buy
+180,954
New +$7.8M ﹤0.01% 2431
2018
Q3
– Sell
-9,671
Closed -$413K – 9658
2018
Q2
$387K Sell
9,671
-24,549
-72% -$966K ﹤0.01% 6789
2018
Q1
$1.37M Sell
34,220
-11,737
-26% -$488K ﹤0.01% 4319
2017
Q4
$1.98M Buy
+45,957
New +$2.12M ﹤0.01% 3656
2017
Q3
– Sell
-28,552
Closed -$1.38M – 8009
2017
Q2
$1.37M Buy
+28,552
New +$1.36M ﹤0.01% 3656
2017
Q1
– Sell
-18,710
Closed -$794K – 7994
2016
Q4
$757K Buy
+18,710
New +$737K ﹤0.01% 4256
2016
Q2
– Sell
-56,533
Closed -$2.32M – 7525
2016
Q1
$2.27M Buy
56,533
+19,366
+52% +$778K ﹤0.01% 2584
2015
Q4
$1.58M Buy
37,167
+16,568
+80% +$762K ﹤0.01% 3097
2015
Q3
$978K Buy
+20,599
New +$1.05M ﹤0.01% 3976
2014
Q4
– Sell
-5,300
Closed -$299K – 8897
2014
Q3
$299K Buy
+5,300
New +$285K ﹤0.01% 5416
2013
Q4
– Sell
-24,594
Closed -$1.24M – 7155
2013
Q3
$1.24M Sell
24,594
-10,483
-30% -$533K ﹤0.01% 2873
2013
Q2
$1.81M Hold
35,077
– – ﹤0.01% 2596

Other funds holding SNY

Ken Griffin's SNY Position: Q3 2026 in Review

Ken Griffin reduced its Sanofi (SNY) stake by 59% in Q3 2026, selling an estimated $47.9M and leaving 750,639 shares worth $30.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2066.

Ken Griffin first reported a position in SNY in Q2 2013 and has held it in 40 quarters since. The position peaked at $79M in Q2 2026. 692 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Ken Griffin held 750,639 shares of Sanofi worth $30.9M as of Q3 2026.
  • Ken Griffin sold 1,101,568 Sanofi shares in Q3 2026, an estimated $47.9M.
  • Sanofi made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #2066 holding.
  • Ken Griffin first reported a position in Sanofi in Q2 2013 and has held it in 40 quarters since.
  • Ken Griffin's Sanofi position peaked at $79M in Q2 2026.
  • 692 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.